Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The neurite outgrowth factor Netrin-1 (NTN1) is one of the members of the Netrin family and is secreted by the bottom plate. It is the earliest soluble neurite outgrowth factor discovered and is highly expressed in many species of the nervous system.
Figure 1. NTN1 in nerve regeneration. (Dun, X., et al. 2017)
The Structure and Function of NTN1
NTN1 is the earliest cell secreted soluble protein isolated and identified and named in the Netrin family, and is highly expressed in the nervous system of many species. NTN1 is highly conserved in structure and has a molecular weight of approximately 80 kD. It is a secretable protein associated with the laminin gamma short arm. It contains 6 recognizable domains. Its 450 amino acids at the N-terminus are similar to the N-terminus of laminin, but the 150 amino acids at the C-terminus are different from laminin. NTN1 relies on receptors to transmit signals by binding to immunoglobulin-like transmembrane receptors. Its receptors can be divided into a variety of types, including deleted in colorectal cancer (DCC) and its analog neogenin; UNC5 homolog (UNC-5 homolog, UNC5H), including UNC5A, UNC5B, UNC5C. In recent years, four other receptors of NTN1 have been discovered, namely Down syndrome cell adhesion molecule (DSCAM), adenosine A2b receptor, integrin α6β4 and α3β1. In the process, NTN1 guides the directional migration and growth of nerve axons and regulates the development and differentiation of neurons. Subsequent research found that NTN1 and its receptors are widely distributed in tissues, and play a variety of roles in tissues outside the nervous system. For example, NTN1 positively and negatively regulates the growth of the vasculature, regulates the migration of leukocytes, adhesion and migration of intestinal epithelial cells, and the development and differentiation of the lung and pancreas, and NTN1 and its receptors are used in various tumors.
Alzheimer's disease (AD) is a hidden chronic degenerative nervous system disease. Research suggests that several domains of NTN1 are used in AD to bind to the corresponding site of the DCC receptor and then specifically bind to the amyloid precursor protein to reduce the production of β-amyloid (Aβ), thereby delaying the progress of dementia. The study found that the decreased expression of NTN1 is related to the increase of Aβ concentration, which shows that NTN1 is an important regulator of Aβ production. Therefore, the concentration ratio of Aβ peptide to NTN1 in the brain is meaningful as a key determinant of AD development. The study found that microinjection of Aβ1-42 into the bilateral hippocampus caused a significant loss of neurons in the CA1 area of the AD mouse model. Microinjection of NTN1 in the hippocampus of AD mice prevented the loss of neurons and reached or approached the neuron count of the normal control group, thereby improving the behavior and cognitive function of AD mice.
NTN1 can participate in tumorigenesis, development and metastasis processes by regulating apoptosis. NTN1 can participate in regulating apoptosis from multiple pathways. The high expression of NTN1 in tumor cells is helpful to help it escape its receptor-mediated apoptosis. For example, the autocrine NTN1 expression in tumor cells may inhibit UNC5H-induced cell death. That is, NTN1 can break the cell survival balance through these pathways and participate in the tumorigenesis process. In addition, NTN1 can regulate tumor morphogenesis, development and metastasis by regulating tumor angiogenesis. In recent years, several studies have confirmed that NTN1 plays an important role in the formation of tissues and the formation of the vascular system.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.